Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Fuji
Colorcon
UBS
Baxter
Medtronic
US Department of Justice
Boehringer Ingelheim
Chubb
US Army

Generated: October 22, 2017

DrugPatentWatch Database Preview

PAREDRINE Drug Profile

« Back to Dashboard

Which patents cover Paredrine, and when can generic versions of Paredrine launch?

Paredrine is a drug marketed by Pharmics and is included in one NDA.

The generic ingredient in PAREDRINE is hydroxyamphetamine hydrobromide. There are two drug master file entries for this compound. Additional details are available on the hydroxyamphetamine hydrobromide profile page.

Summary for Tradename: PAREDRINE

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list25
Patent Applications: see list43
Drug Prices:see details
DailyMed Link:PAREDRINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmics
PAREDRINE
hydroxyamphetamine hydrobromide
SOLUTION/DROPS;OPHTHALMIC000004-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Citi
Fuji
Mallinckrodt
Chinese Patent Office
UBS
McKinsey
Cerilliant
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot